Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takayuki Sumiyoshi

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate CancerSofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, et al.
British Journal of Cancer|November 19, 2023
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)Jimmy L Zhao, Emmanuel S Antonarakis, Heather H Cheng, et al.
International Journal of Clinical Oncology|July 19, 2024
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensityHiroshi Fujiwara, Masashi Kubota, Yu Hidaka, et al.
Clinical Genitourinary Cancer|July 31, 2025
Risk Stratification for the Prognosis of Patients With pT3aN0M0 Clear Cell Renal Cell CarcinomaShigeki Koterazawa, Takayuki Sumiyoshi, Katsuhiro Ito, et al.
Iscience|June 24, 2026
IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft modelRyuta Sobu, Yuka Kobayashi, Soki Kashima, et al.
Scientific Reports|March 11, 2024
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomyMasashi Kubota, Mutsushi Kawakita, Satomi Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate CancerKei Mizuno, Takayuki Sumiyoshi, Takatsugu Okegawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 3, 2013
Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter studyYoshikazu Togo, Shiro Tanaka, Akihiro Kanematsu, et al.
Nature Communications|February 28, 2024
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancerNicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 30, 2023
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate CancerSofie H Tolmeijer, Emmy Boerrigter, Takayuki Sumiyoshi, et al.
British Journal of Cancer|November 19, 2023
Phase 1b study of enzalutamide plus CC-115, a dual mTORC1/2 and DNA-PK inhibitor, in men with metastatic castration-resistant prostate cancer (mCRPC)Jimmy L Zhao, Emmanuel S Antonarakis, Heather H Cheng, et al.
International Journal of Clinical Oncology|July 19, 2024
A novel prognostic model of de novo metastatic hormone-sensitive prostate cancer to optimize treatment intensityHiroshi Fujiwara, Masashi Kubota, Yu Hidaka, et al.
Clinical Genitourinary Cancer|July 31, 2025
Risk Stratification for the Prognosis of Patients With pT3aN0M0 Clear Cell Renal Cell CarcinomaShigeki Koterazawa, Takayuki Sumiyoshi, Katsuhiro Ito, et al.
Iscience|June 24, 2026
IL-8 blockade enhances anti-PD-1 therapeutic activity in renal cell carcinoma in a next-generation patient-derived xenograft modelRyuta Sobu, Yuka Kobayashi, Soki Kashima, et al.
Scientific Reports|March 11, 2024
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomyMasashi Kubota, Mutsushi Kawakita, Satomi Yoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2021
Clinical Impact of Detecting Low-Frequency Variants in Cell-Free DNA on Treatment of Castration-Resistant Prostate CancerKei Mizuno, Takayuki Sumiyoshi, Takatsugu Okegawa, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 3, 2013
Antimicrobial prophylaxis to prevent perioperative infection in urological surgery: a multicenter studyYoshikazu Togo, Shiro Tanaka, Akihiro Kanematsu, et al.
Nature Communications|February 28, 2024
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancerNicolette M Fonseca, Corinne Maurice-Dror, Cameron Herberts, et al.
Pageof 8